| ID | 1667 |
|---|
| No | 1667 |
|---|
| Brand Name | SOTOKRAS |
|---|
| Ingredients | SOTORASIB 120 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 56'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH KRAS G12C-MUTATED LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC), WHO HAVE RECEIVED AT LEAST ONE PRIOR SYSTEMIC THERAPY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | YELLOW, ROUND TABLET, EMBOSSED WITH 120 ON ONE SIDE AND PLAIN ON THE OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 06 L 0981/23 |
|---|
| FDD Registration Date | 28/06/2023 |
|---|
| Expiry Date | 27/06/2026 |
|---|
